Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »
Sep 1, 2013 (Vol. 33, No. 15)

Exploiting Cells’ Electrical Behavior

  • The “Analytical and Monitoring” track at the recent “European Society for Animal Cell Technology” was notable for three presentations on advanced techniques based on the electrical capacitance of cells in media.

    At the conference, Katrin Braasch, a doctoral student at the University of Manitoba, presented data on five independent methods for determining cell density and/or viability. Her techniques include particle counting, image analysis with trypan blue exclusion, on-line capacitance, off-line flow cytometer apoptosis kits, and a novel dielectrophoretic (DEP) cytometer.

    Developed at U. Manitoba (Thomson and Bridges group), the DEP cytometer analyzes individual CHO cells through radiofrequency actuation in a narrow capillary. This technique, which relies on shifts in dielectric properties corresponding to loss of cell viability, is capable of identifying sub-populations of cells during apoptosis, which may be further characterized through fluorescence markers and capacitance.

    During the measurement with the DEP prototype, a cell suspension diluted in low-conductivity medium is passed through a microfluidic channel, where individual cells pass over an electrode array that detects and vertically displaces the cells. The degree of displacement directly relates to the cell’s polarizability, which in turn correlates with the cells’ metabolic health and viability.

    “Our results show that the various on- and off-line techniques gave similar values during exponential phase and that measurements diverged only at the point of highest cell density,” Braasch said. She found that the intermediate-stage apoptosis assay agreed with data from the bulk capacitance probe, while early-stage apoptosis measurements correlated with the DEP cytometer.

    Both bulk capacitance and DEP cytometry allow for earlier detection of apoptosis than trypan blue exclusion, the standard apoptosis assay in use today. Earlier detection prompts investigators to harvest at that stage, or alter the feeding strategy to extend culture life.

    “While trypan blue viability assays remain standard, it only picks up cells at the end stage of apoptosis, well after the loss of cell viability is detected by the bulk capacitance probe and the DEP cytometer,” Braasch explained. “This makes the DEP cytometer a potential low-cost, online viability measurement tool.”

    DEP allows Braasch to map the trajectory of viability in CHO cells, including identifying subpopulations associated with various stages of apoptosis, and to distinguish viable from nonviable cells.

    It is also possible to identify subpopulations of apoptosis in a bioprocess using flow cytometer assays. However, flow cytometry assays are expensive and time consuming because of incubation times required for staining protocols. DEP works without staining.

    Despite the trend toward online and inline monitoring, offline methods such as cell counting, and at-line semi-automated techniques still dominate biomass detection. Yet both approaches are time consuming and are incapable of monitoring a process continuously.

    One emerging “electrical” technique, radiofrequency impedance (RFI) detection, is capable of in situ viable biomass detection and is well established in biopharmaceutical processing, but only in traditional glass and stainless steel bioreactors.

    “Biomass characterization and measurement is one of the most requested parameters in bioprocessing,” said John Carvell, Ph.D., sales and marketing director at Aber Instruments. “Knowledge of the biomass progress during a fermentation provides deeper process knowledge and control, and helps to define induction, harvest, or infection points.”

    RFI detection exploits the fact that healthy living cells act like electrical capacitors, accumulating then releasing electrical charges. The phenomenon applies to both suspended and attachment-dependent cells on microcarriers. “Compromised cells lose that capacity,” Dr. Carvell told GEN.

    RFI detection correlates well with trypan blue staining until cells begin to enter their death phase. Several recent papers explain the differences between RFI and standard live-cell counting methods. The Aber sensor matches the Guava ViaCount assay during the death phase, but detects the onset of apoptosis earlier than the trypan blue. So which test is more accurate? “Unfortunately, there is no gold-standard test for live-cell concentration,” Dr. Carvell explained.

    Carvell’s work becomes increasingly important as more processes become “born and bred” in plastic. The RFI probes must be compatible with single-use equipment’s agitation, aeration, and capacity for gamma sterilization, and work through signal fluctuations due to variability of liquid level (particularly in rocking bio-bags). Cost must be reasonable as well, since the probes are disposable.

    The Aber probes consist of four annular ring electrodes that monitor current and voltage inside the culture. In the absence of cells, current and voltage are in synch. Due to the nature of capacitance, as cell density increases, voltage and current become out of phase. Only living cells containing a conducting cytoplasm enclosed with an intact nonconducting membrane are polarized under the electric field, which is how RFI distinguishes between living and dead cells or debris.

    While it may be novel for bioprocessors, RFI detection is not a new technology. Many such systems are installed in breweries across the United States to allow accurate yeast dosing at the beginning of each fermentation.

    A team led by Lisa Graham, Ph.D., senior VP at Bend Research, is exploring the capabilities of using scanning multifrequency dielectric spectroscopy (SMFDS) to profile multiple bioreactor runs and quantify cell viability.

    Dielectric spectroscopy measures the capacitance, or charge-storing characteristics, of samples across a spectrum of frequencies. In the case of cells, this charging happens via a phenomenon known as Maxwell-Wagner polarization, which occurs because of the nonconductive nature of cellular membranes. Dielectric spectroscopy takes advantage of this characteristic by treating electrical measurements from cells in media as if they were an electrical circuit. The number of capacitors (cells) and the properties of the dielectric comprising them (size, morphology, ion content, membrane composition) affect the shape of the dielectric spectrum and can, therefore, be measured.

    “Dielectric spectroscopy yields critical information about cell number, cell health and viability, metabolic changes, and morphology of different cell populations,” Dr. Graham said. “The challenge is to link physical measurements of cell properties with the biological information we are after.” To achieve this, the dielectric data must be viewed in the context of metabolite data. “Much of the development of dielectric spectroscopy—and pretty much all process analytical technology (PAT) methods available today—requires systems capable of handling large, disparate datasets and analyzing the data in a way that provides real process guidance.”

    The group at Bend Research has resolved multiple cell populations within the context of apoptosis. Other groups, Dr. Graham said, have reported changes in cell populations associated with metabolic changes, cell size, membrane composition, and cell morphology.

Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »